Total Payments
$729,341
2024 Payments
$155,754
Companies
27
Transactions
814
Payment Breakdown by Category
Other$470,144 (64.5%)
Consulting$168,974 (23.2%)
Travel$72,515 (9.9%)
Food & Beverage$16,698 (2.3%)
Research$730.02 (0.1%)
Education$280.30 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $262,122 | 108 | 35.9% |
| Honoraria | $208,023 | 90 | 28.5% |
| Consulting Fee | $168,974 | 57 | 23.2% |
| Travel and Lodging | $72,515 | 281 | 9.9% |
| Food and Beverage | $16,698 | 269 | 2.3% |
| Unspecified | $730.02 | 1 | 0.1% |
| Education | $280.30 | 8 | 0.0% |
Payments by Type
General
$728,611
813 transactions
Research
$730.02
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $180,068 | 257 | $0 (2019) |
| CSL Behring | $169,575 | 222 | $0 (2024) |
| Horizon Therapeutics plc | $126,429 | 105 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $113,367 | 77 | $0 (2024) |
| Pharming Healthcare, Inc. | $70,782 | 70 | $0 (2024) |
| Amgen Inc. | $46,791 | 29 | $0 (2024) |
| X4 Pharmaceuticals, Inc. | $12,480 | 10 | $0 (2024) |
| PFIZER INC. | $3,951 | 3 | $0 (2023) |
| Janssen Research & Development, LLC | $2,805 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $730.02 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $155,754 | 128 | Pharming Healthcare, Inc. ($51,098) |
| 2023 | $74,240 | 69 | Horizon Therapeutics plc ($35,277) |
| 2022 | $78,249 | 82 | CSL Behring ($35,333) |
| 2021 | $76,847 | 74 | Horizon Therapeutics plc ($37,421) |
| 2020 | $41,424 | 39 | Horizon Therapeutics plc ($26,859) |
| 2019 | $99,612 | 120 | Shire North American Group Inc ($52,981) |
| 2018 | $87,177 | 107 | Shire North American Group Inc ($56,956) |
| 2017 | $116,038 | 195 | Shire North American Group Inc ($70,130) |
All Payment Transactions
814 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Consulting Fee | Cash or cash equivalent | $4,717.50 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $510.00 | General |
| 12/05/2024 | Amgen Inc. | ACTIMMUNE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Bone/Inflammation/Rare Disease | ||||||
| 12/02/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Consulting Fee | Cash or cash equivalent | $3,052.50 | General |
| Category: Immunology | ||||||
| 12/02/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Consulting Fee | Cash or cash equivalent | $1,942.50 | General |
| Category: Immunology | ||||||
| 11/22/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Travel and Lodging | Cash or cash equivalent | $492.95 | General |
| Category: Immunology | ||||||
| 11/22/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 11/21/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | Cash or cash equivalent | $73.39 | General |
| Category: BIOLOGIC | ||||||
| 11/19/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Consulting Fee | Cash or cash equivalent | $555.00 | General |
| Category: Immunology | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Travel and Lodging | Cash or cash equivalent | $707.27 | General |
| Category: Immunology | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Travel and Lodging | Cash or cash equivalent | $611.95 | General |
| Category: Immunology | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $135.38 | General |
| Category: Immunology | ||||||
| 11/06/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Travel and Lodging | Cash or cash equivalent | $129.68 | General |
| Category: Immunology | ||||||
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $120.62 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,217.50 | General |
| 10/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $44.46 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $136.53 | General |
| Category: BIOLOGIC | ||||||
| 10/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $70.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/26/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $52.17 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/22/2024 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $202.40 | General |
| 10/22/2024 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $102.92 | General |
| 10/21/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 10/21/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive HCM) | E.R. Squibb & Sons, L.L.C. | $730.02 | 1 |
About Niraj Patel, MD, MS
Niraj Patel, MD, MS is a Pediatric Allergy/Immunology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407940596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Niraj Patel, MD, MS has received a total of $729,341 in payments from pharmaceutical and medical device companies, with $155,754 received in 2024. These payments were reported across 814 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($262,122).
Ad
Practice Information
- Specialty Pediatric Allergy/Immunology
- Other Specialties Pediatric Allergy/Immunology
- Location Durham, NC
- Active Since 10/03/2006
- Last Updated 11/29/2022
- Taxonomy Code 2080P0201X
- Entity Type Individual
- NPI Number 1407940596
Products in Payments
- Hizentra (Biological) $156,503
- ACTIMMUNE (Drug) $126,213
- CUVITRU (Biological) $123,100
- HYQVIA (Biological) $70,815
- CINRYZE (Drug) $54,481
- ACTIMMUNE (Biological) $31,637
- JOENJA (Drug) $24,300
- XOLREMDI (Drug) $12,480
- Haegarda (Biological) $6,394
- Privigen (Biological) $3,370
- PANZYGA (Biological) $2,220
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $1,665
- GAMMAGARD LIQUID (Biological) $1,650
- Multiple Products (Biological) $1,426
- RUCONEST (Biological) $831.85
- ORLADEYO (Drug) $447.64
- TEZSPIRE (Biological) $220.00
- DUPIXENT (Biological) $177.09
- QVAR (Drug) $139.18
- PROAIR (Drug) $138.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.